384
Participants
Start Date
September 30, 2012
Primary Completion Date
March 31, 2016
Study Completion Date
March 31, 2016
Single dose rifaximin 1650 mg
Rifaximin 1650 mg as a single dose plus loperamide 4 mg initially followed by 2 mg after each unformed stool, not to exceed 16 mg/day for 2 days
Single dose azithromycin 500 mg
Azithromycin 500 mg as a single dose plus loperamide 4 mg initially followed by 2 mg after each unformed stool, not to exceed 16 mg/day for 2 days
Single dose levofloxacin 500 mg
Levofloxacin 500 mg as a single dose plus loperamide 4 mg initially followed by 2 mg after each unformed stool, not to exceed 16 mg/day for 2 days
Single dose azithromycin 1000 mg plus loperamide
Azithromycin 1000 mg as a single dose plus loperamide 4 mg initially followed by 2 mg after each unformed stool, not to exceed 16 mg/day for 2 days
Single dose azithromycin 1000 mg plus placebo
Azithromycin 1000 mg as a single dose and placebo in lieu of loperamide
UK Role 3 Joint Force Hospital, Camp Bastion Air Base
U.S. Naval Expeditionary Base, Camp Lemonnier
Joint Task Force - Bravo, Soto Cano Air Base
British Army Training Unit Kenya, Nanyuki
Armed Forces Research Institute of Medical Sciences, Bangkok
Navy Bureau of Medicine and Surgery
FED
Ministry of Defence, United Kingdom
OTHER_GOV
Naval Medical Research Center
FED
Naval Medical Research Unit- 3
FED
United States Army Medical Unit - Kenya
FED
United States Naval Medical Center, Portsmouth
FED
Naval Medical Research Unit- 6
FED
Uniformed Services University of the Health Sciences
FED